Showing 1,201 - 1,220 results of 5,845 for search '(( significant decrease decrease ) OR ( significance ((we decrease) OR (a decrease)) ))~', query time: 0.29s Refine Results
  1. 1201

    C2f-E improvement process. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  2. 1202

    Structure of Detect and GP-Detect. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  3. 1203

    YOLOv8 structure and working principle. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  4. 1204

    Improvement of CBS to CBR process. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  5. 1205

    EMA attention mechanism working principle. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  6. 1206

    Ablation study on the NWPU VHR-10 dataset. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  7. 1207

    GSConv working principle. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  8. 1208

    PR comparison on NWPU VHR-10 dataset. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  9. 1209

    Image2_GABA Type A receptors expressed in triple negative breast cancer cells mediate chloride ion flux.TIF by J Bundy (19843944)

    Published 2024
    “…Here, using surface biotinylation and (N-(Ethoxycarbonylmethyl)-6-Methoxyquinolinium Bromide) MQAE-dye based fluorescence quenching, we show that upregulated GABA<sub>A</sub>R are on the cell-surface in TNBC cell lines and mediate significantly higher chloride (Cl<sup>−</sup>) flux as compared to non-tumorigenic MCF10A cells. …”
  10. 1210

    Image1_GABA Type A receptors expressed in triple negative breast cancer cells mediate chloride ion flux.TIF by J Bundy (19843944)

    Published 2024
    “…Here, using surface biotinylation and (N-(Ethoxycarbonylmethyl)-6-Methoxyquinolinium Bromide) MQAE-dye based fluorescence quenching, we show that upregulated GABA<sub>A</sub>R are on the cell-surface in TNBC cell lines and mediate significantly higher chloride (Cl<sup>−</sup>) flux as compared to non-tumorigenic MCF10A cells. …”
  11. 1211

    Primers for quantitative real-time PCR. by Ya-nan Hu (12508990)

    Published 2024
    “…</p><p>Conclusions</p><p>In this study, we identified two heterozygous pathogenic variants in the <i>LDLR</i> gene, c.G1027A (p.Gly343Ser) and c.G1879A (p.Ala627Thr), in a family with familial hypercholesterolemia. …”
  12. 1212
  13. 1213

    Metals concentrations in selected coal samples. by Ruchika Kishor Jain (19704102)

    Published 2024
    “…After BAI-RCD treatment, both cell lines showed a decrease in antioxidant stress measures (SOD, CAT, and GSH) and a significant (<i>p</i> < 0.001) increase in oxidative stress parameters (NADPH, MPO, LPO, and PC). …”
  14. 1214

    Weight and plasma biochemistry. by Søren Egstrand (10906087)

    Published 2025
    “…<div><p>Secondary hyperparathyroidism (sHPT) is a significant clinical complication of CKD leading to bone abnormalities and cardiovascular disease. …”
  15. 1215

    Baseline clinical data. by Lu-Jin Cheng (21743350)

    Published 2025
    “…In vitro experiments showed that the addition of Gal-9 led to a significant increase in the proportion of TIM-3<sup>+</sup>M1 and TIM-3<sup>+</sup>M2 macrophages and a decrease in M1 cell proportions and M1/M2 ratio. …”
  16. 1216
  17. 1217

    Imformation. by Shicheng Luo (14349225)

    Published 2025
    “…Flow cytometry revealed a significant decrease in the apoptosis of HK-2 cells. …”
  18. 1218

    Scale scores of all participants. by Sylwia Sumińska (21169999)

    Published 2025
    “…In contrast, in the MBSR group without smartwatches, there was a significant decrease across multiple stress-related components, including: anxiety, cognitive impairment, addictions, sleep disorders symptoms, behaviors indicating lack of entertainment, and poor functioning.…”
  19. 1219

    DataSheet1_Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD.doc by Hyun-ju Lee (7550741)

    Published 2024
    “…</p>Results and discussion<p>We found that erlotinib significantly enhanced short-term spatial memory and dendritic spine formation in 6-month-old P301S tau transgenic (PS19) mice. …”
  20. 1220

    Key safety measures including adverse events. by Anuja Dokras (8679261)

    Published 2025
    “…<div><p>Background</p><p>The risk-to-benefit ratio of using combined oral contraceptive pills (COCPs) and/or metformin for comprehensive management of polycystic ovary syndrome (PCOS) in women with obesity is unclear. As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”